Status:
COMPLETED
An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice
Lead Sponsor:
AstraZeneca
Conditions:
Nosocomial Infection
Eligibility:
All Genders
Brief Summary
The present study is a retrospective cohort study on patients who suffered a nosocomial infection in major hospitals in Vietnam. Data relating to patient demography include age, gender; medical histor...
Eligibility Criteria
Inclusion
- Patient was diagnosed as nosocomial infection defined according to criteria established by the US CDC. The diagnosis criteria for ventilator-associated pneumonia are modified from those established by the American College of Chest Physicians.
- Patient received empiric antimicrobial therapy within 24 hour from onset of infection and had antimicrobial susceptibility.
Exclusion
- A patient was in part of a controlled clinical trial for the current infection episode.
- Patients with suspected infections by virus or fungus or tuberculosis will be excluded.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00864929
Start Date
November 1 2009
End Date
October 1 2010
Last Update
February 16 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Hanoi, Vietnam
2
Research Site
Ho Chi Minh City, Vietnam